Efficacy Study on Dimethyl Fumarate to Treat Moderate to Severe Plaque Psoriasis
Phase 3
Withdrawn
- Conditions
- Plaque Psoriasis
- Interventions
- First Posted Date
- 2013-03-21
- Last Posted Date
- 2016-08-09
- Lead Sponsor
- Forward-Pharma GmbH
- Registration Number
- NCT01815723
- Locations
- 🇨🇦
Probity Medical Research, Waterloo, Ontario, Canada
Pivotal Efficacy and Safety Registration Trial of FP187 in Moderate to Severe Plaque Psoriasis
Phase 2
Completed
- Conditions
- Plaque Psoriasis
- Interventions
- Drug: FP187Drug: Placebo
- First Posted Date
- 2010-10-28
- Last Posted Date
- 2012-12-11
- Lead Sponsor
- Forward-Pharma GmbH
- Target Recruit Count
- 252
- Registration Number
- NCT01230138
- Locations
- 🇩🇪
Dermatological Dept., Uniklinikum, TU-Dresden, Dresden, Germany
🇩🇪SCIderm, Hamburg, Germany
© Copyright 2025. All Rights Reserved by MedPath